Celegence COO Punya Abbhi featured in Life Science Leader
Our COO Punya Abbhi shares valuable perspectives Life Science Leader on how Generative AI (GenAI) technology is disrupting the way all kinds of organizations filter, find, and process knowledge and content, and this could impact the cost of regulatory medical writing.
Article Highlights
The article focuses on:
- Opportunities to bridge the skill gap in medical writing identified in new research that Celegence conducted
- Specific use cases are discussed around regulatory documentation and safety report summaries.
- Strategies that companies can take to leverage both the technology and industry expertise.
Read the full article in Life Science Leader.
Celegence’s Expertise
Celegence has proven experience with medical writing for regulatory submissions. Our deep regulatory expertise, combined with advanced AI-Enabled technology solutions, positions us uniquely to handle the complexities of medical writing. We ensure that every document is not only compliant but crafted to expedite approval processes and facilitate market access. For more information about our services can benefit your regulatory processes, contact us today.